Patients with type 2 diabetes will be able to access total diet replacement products as part of a remission programme to be rolled out in some areas of the UK this week.

The year-long plan will be offered to 5,000 more patients in 10 areas and those selected will be given shakes and soups for three months, alongside support to increase their exercise levels, virtual one-to-ones, group sessions and digital support.

Bridget Turner, Director of Policy Campaigns and Improvement at Diabetes UK, said:”This is an important first step to ensure that people with type 2 diabetes, can access a remission programme within the NHS and benefit from the ground-breaking findings of the Diabetes UK funded DiRECT research.

“We know that some people with type 2 diabetes want and need support from health care professionals to lose weight effectively and now as these programmes are piloted across the NHS – they will.

“People with type 2 diabetes who have put their diabetes into remission frequently tell us how it has changed their lives. We are so pleased to see that others will now have the same opportunity and hope that it won’t be too long before more remission programmes are rolled out across the country.”

One in 20 GP prescriptions is for diabetes

Diabetes is estimated to cost the NHS £10 billion a year, while almost one in 20 prescriptions written by GPs is for diabetes treatment.

To help people maintain a healthy lifestyle and avoid complications linked to obesity patients will also be offered managed plans for reintroducing ordinary, nutritious food, with ongoing support from clinicians and coaches after that.

The sites rolling out the low-calorie diet programme are:

  • North East and Yorkshire: South Yorkshire & Bassetlaw ICS, and Humber Coast & Vale STP
  • North West: Greater Manchester Health & Social Care Partnership
  • South East: Frimley Health and Care STP
  • South West: Gloucestershire STP
  • Midlands (West and East): Derbyshire STP, and Birmingham and Solihull STP
  • East of England: Bedfordshire, Luton and Milton Keynes (BLMK) ICS
  • London: North East London, and North Central London

Sites across the country will test evidence from the original trials in a ‘real world’ implementation during a 12-month treatment course.

People living with type 2 diabetes who have been diagnosed with the condition in the last six years will be considered for the pilots. Individuals must also meet other eligibility criteria to be referred to the service to ensure the programme is right for them.


For more news and article on Type 2 diabetes go to our endocrinology section